N- (3,5- diamino- 6- chloropyrazine- 2- carbonyl)- N'- (4- (4- (2,3- dihydroxypropoxy)phenyl)butyl)guanidine
an epithelial sodium channel blocker for treating cystic fibrosis and chronic bronchitis; structure in first source
Also Known As:
DCC-DPBG compound; N-(3,5-diamino-6-chloropyrazine-2-carbonyl)-N'-4-(4-(2,3-dihydroxypropoxy)phenyl)butylguanidine; P552-02
Networked: 0
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results